Racial variations in erythropoietic response to epoetin alfa in chronic kidney disease and the impact of smoking

Nephrology Dialysis Transplantation

Volumn 20, Issue 12, 2005, Pages 2739-2745

  Jones Burton, Charlotte ^a   Seliger, Stephen L ^a   Brown, Jeanine ^b   Stackiewicz, Lucy ^b   Hsu, Van Doren ^c   Fink, Jeffrey C ^a,b,d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^d UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

Author keywords

Anaemia; Chronic kidney disease; Epoetin alfa; Race; Smoking

Indexed keywords

ALBUMIN; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ADULT; AFRICAN AMERICAN; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RACE DIFFERENCE; SMOKING; STATISTICAL ANALYSIS;

AFRICAN AMERICANS; AGED; ANEMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOETIN ALFA; ERYTHROPOIESIS; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HEMATINICS; HEMOGLOBINS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TREATMENT OUTCOME; UNITED STATES;

EID: 27944437884     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi128     Document Type: Article

References (19)

1. Tarver-Carr ME, Powe NR, Eberhardt MS et al. Excess risk of chronic kidney disease among African-American versus white subjects in the United States: A population-based study of potential explanatory factors. J Am Soc Nephrol 2002; 13: 2363-2370
2. US Renal Data System, USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, Md. 2003
3. Maschio G, Marcantoni C, Bernich P. Lessons from large interventional trials on antihypertensive therapy in chronic renal disease. Nephrol Dial Transplant 2002; 17 [Suppl 11]: 47-49
4. Wright JT, Jr, Bakris G, Greene T et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA 2002; 288: 2421-2431
5. Hsu CY, Lin F, Vittinghoff E, Shlipak MG. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 2003; 14: 2902-2907
6. Pinto-Sietsma SJ, Mulder J, Janssen WM et al. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 2000; 133: 585-591
7. Chuahirun T, Simoni J, Hudson C et al. Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes. Am J Med Sci 2004; 327: 57-67
8. Sagone AL, Jr, Balcerzak SP. Smoking as a cause of erythrocytosis. Ann Intern Med 1975; 82: 512-515
9. Smith JR, Landaw SA. Smokers' polycythemia. N Engl J Med 1978; 298: 6-10
10. Schiffl H, Lang SM, Fischer R. Stopping smoking slows accelerated progression of renal failure in primary renal disease. J Nephrol 2002; 15: 270-274
11. Stengel B, Couchoud C, Cenee S, Hemon D. Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies. Kidney Int 2000; 57: 2519-2526
12. Provenzo R, Garcia-Mayol L, Suchinda P et al. and the POWER STUDY GROUP. Once-weekly epoetin alfa for treating the anemia of chronic kidney disease. Clin Nephrol 2004; 61: 392-405
13. Levey AS, Greene T, Kusik JW, Beck GJ, and the Modification of Diet in Renal Disease Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: 155A (abstract A0828)
14. Centers for Disease Control and Prevention. Cigarette smoking among adults - United States, 2001. MMWR 2003; 52: 953-956
15. Haroun MK, Jaar BG, Hoffman SC et al. Risk factors for chronic kidney disease: A prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 2003; 14: 2934-2941
16. Exner DV, Dries DL, Domanski MJ, Cohn JN. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N Engl J Med 2001; 344: 1351-1357
17. Bailie GR, Eisele G, Liu L et al. Patterns of medication use in the RRI-CKD study: Focus on medications with cardiovascular effects. Nephrol Dial Transplant 2005; 20: 1110-1115
18. Patrick DL, Cheadle A, Thompson DC et al. The validity of self-reported smoking: A review and meta-analysis. Am J Public Health 1994; 84: 1086-1093
19. Olivarius NF, Andreasen AH, Keiding N, Mogensen CE. Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study "Diabetes Care in General Practice", Denmark. Diabetologia 1993; 36: 1007-1016